Know Labs, Inc. , a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its fiscal year ending September 30, 2024, and ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its A ...

In recent years, technological advancements in healthcare have revolutionised the management of chronic conditions like ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and fiscal ...

A novel system combining high-speed video and AI algorithms could revolutionize health screenings for high blood pressure and ...

Thailand-based Disrupt Health Impact Fund closed its first deal by investing in DiaMonTech, a Germany-based deep tech startup ...

Disrupt Technology Venture, also known as Disrupt, continues to strengthen the healthcare ecosystem with its Disrupt Health ...

Berlin-based Quantune is trying to shrink laser spectrometers so that you can wear one on your wrist, and it just raised $9M ...